The deployment of the HPV vaccine to prevent the Human Papillomavirus (HPV) infection among young females in the country followed the approval granted by the National Agency for Food and Drug Administration and Control, (NAFDAC) on use of Gardasil vaccine as single dose in the routine immunisation against cervical cancer.
Speaking at a joint press briefing with the Director General of NAFDAC, Prof. Mojisola Adeyeye, in Abuja, the Executive Secretary of the National Primary Health Care Development Agency (NPHCDA) , Dr. Faisal Shuaib, said the commencement date for the deployment of the HPV vaccine would be Tuesday, October 24, 2023.
